Hybrid Pharmaceuticals Possessing Protease and Histone Deacetylase Inhibition Activity for the Development of Curative HIV Treatment: Design, Synthesis, and Preliminary Evaluation
Hybrid Pharmaceuticals Possessing Protease and Histone Deacetylase Inhibition Activity for the Development of Curative HIV Treatment: Design, Synthesis, and Preliminary Evaluation
具有蛋白酶和组蛋白脱乙酰酶抑制活性的混合药物，用于开发治疗性 HIV 治疗：设计、合成和初步评估
批准号：
464910-2014
负责人：
Elmehriki, AdamAbdelHamid
金额：
$1.27万
依托单位：
依托单位国家：
加拿大
项目类别：
Alexander Graham Bell Canada Graduate Scholarships - Master's
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-01-01 至 2015-12-31
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Hybrid Antiretroviral Pharmaceuticals Towards a Curative Treatment for Human Immunodeficiency Virus Infection
-
批准号：475491-2015
-
项目类别：Postgraduate Scholarships - Doctoral
-
资助金额：$1.53万
-
财政年份：2017
-
负责人：Elmehriki, AdamAbdelHamid
-
依托单位：
Development of Hybrid Antiretroviral Pharmaceuticals Towards a Curative Treatment for Human Immunodeficiency Virus Infection
-
批准号：475491-2015
-
项目类别：Postgraduate Scholarships - Doctoral
-
资助金额：$1.53万
-
财政年份：2016
-
负责人：Elmehriki, AdamAbdelHamid
-
依托单位：
Development of Hybrid Antiretroviral Pharmaceuticals Towards a Curative Treatment for Human Immunodeficiency Virus Infection
-
批准号：475491-2015
-
项目类别：Postgraduate Scholarships - Doctoral
-
资助金额：$1.53万
-
财政年份：2015
-
负责人：Elmehriki, AdamAbdelHamid
-
依托单位：
海外基金
